The Impact of Post-Hematopoietic Stem Cell Transplant Tyrosine Kinase Inhibitors in Philadelphia-Positive Acute Lymphoblastic Leukemia

Khalid Halahleh; Dalia Al Rimawi; Amal Abu Ghosh; Isra Muradi; Waleed Da’na; Mehdi Hamadani

doi:10.1016/j.hemonc.2021.07.003

Q3 2022

The Impact of Post-Hematopoietic Stem Cell Transplant Tyrosine Kinase Inhibitors in Philadelphia-Positive Acute Lymphoblastic Leukemia

Khalid Halahleh · Dalia Al Rimawi · Amal Abu Ghosh · Isra Muradi · Waleed Da’na · Mehdi Hamadani

10.1016/j.hemonc.2021.07.003 389 المشاهدات 3 الاقتباسات

الاقتباسات

389

المشاهدات

الملخص غير متوفر لهذا المنشور.

الاستشهاد بهذا المقال (APA)

Khalid, H., Dalia, A. R., Amal, A. G., Isra, M., Waleed, D., Mehdi, H. (2022). The Impact of Post-Hematopoietic Stem Cell Transplant Tyrosine Kinase Inhibitors in Philadelphia-Positive Acute Lymphoblastic Leukemia. Hematology/Oncology and Stem Cell Therapy. https://doi.org/10.1016/j.hemonc.2021.07.003

Ghada M. ElGohary; Shahrukh Hashmi; Jan Styczynski; Mohamed A. Kharfan-Dabaja; R · 2022

استشهاد

398

Molecular mediators of breast cancer metastasis

Ragini Yeeravalli; Amitava Das · 2021

استشهاد

388

Venetoclax and decitabine for treatment of relapsed T-cell acute lymphoblastic leukemia

Nosha Farhadfar; Ying Li; William S. May; Carolyn Brooke Adams · 2021

استشهاد

392

Acute upper limb ischemia in a patient with COVID-19